Genetic variation in glutathione metabolism and DNA repair genes predicts survival of small-cell lung cancer patients.

No abstract is available for this paper.

• Publication year

  2010

• Venue

  Annals of Oncology

• Publication date

  2010-10-01

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1093/annonc/mdq212PMID 20439344PMCID PMC2946864
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Prognostic factors for limited-stage small cell lung cancer: a study of 284 patients.

  2010cited by this paper
• Association of genetic polymorphisms in SLCO1B3 and ABCC2 with docetaxel‐induced leukopenia

  2008cited by this paper
• Characterization of Functional Excision Repair Cross-Complementation Group 1 Variants and Their Association with Lung Cancer Risk and Prognosis

  2008cited by this paper
• Glutathione S-transferase M1, T1 and P1 polymorphisms: susceptibility and outcome in lung cancer patients.

  2008cited by this paper
• Associations of ABCB1, ABCC2, and ABCG2 polymorphisms with irinotecan‐pharmacokinetics and clinical outcome in patients with advanced non‐small cell lung cancer

  2007cited by this paper
• Prospective Assessment of XPD Lys751Gln and XRCC1 Arg399Gln Single Nucleotide Polymorphisms in Lung Cancer

  2007influential reference
• DNA repair and survival in lung cancer--the two faces of Janus.

  2007cited by this paper
• Polymorphisms in DNA repair genes modulate survival in cisplatin/gemcitabine-treated non-small-cell lung cancer patients.

  2006influential reference
• Histologic grade is an independent prognostic factor for survival in non-small cell lung cancer: an analysis of 5018 hospital- and 712 population-based cases.

  2006cited by this paper
• The Association Between Polymorphisms in Glutathione S-Transferase (GSTM1 and GSTT1) and Lung Cancer Outcome

  2006cited by this paper
• Treatment of non-small-cell lung cancer and pharmacogenomics: where we are and where we are going

  2006cited by this paper
• Glutathione-S-Transferase P1 Isoenzyme Polymorphisms, Platinum-Based Chemotherapy, and Non-small Cell Lung Cancer

  2006cited by this paper
• DNA repair by ERCC1 in non-small-cell lung cancer and cisplatin-based adjuvant chemotherapy.

  2006cited by this paper
• Association between glutathione S‐transferase π polymorphisms and survival in patients with advanced nonsmall cell lung carcinoma

  2006cited by this paper
• Role of the glutathione metabolic pathway in lung cancer treatment and prognosis: a review.

  2006influential reference
• Clinical features of 5,628 primary lung cancer patients: experience at Mayo Clinic from 1997 to 2003.

  2005cited by this paper
• The polymorphism and haplotypes of XRCC1 and survival of non-small-cell lung cancer after radiotherapy.

  2005cited by this paper
• Association between polymorphisms of ERCC1 and XPD and survival in non-small-cell lung cancer patients treated with cisplatin combination chemotherapy.

  2004cited by this paper
• Excision repair cross complementing-group 1: gene expression and platinum resistance.

  2004cited by this paper
• Genetic susceptibility to tobacco-related cancer

  2004cited by this paper
• XPD and XRCC1 genetic polymorphisms are prognostic factors in advanced non-small-cell lung cancer patients treated with platinum chemotherapy.

  2004influential reference
• Excision Repair Cross-Complementation Group 1 Polymorphism Predicts Overall Survival in Advanced Non-Small Cell Lung Cancer Patients Treated With Platinum-Based Chemotherapy

  2004cited by this paper
• Statistical significance for genomewide studies

  2003cited by this paper
• Glutathione S-transferase M1, T1, and P1 polymorphisms and survival among lung cancer patients.

  2003cited by this paper
• Targeted therapy in combination with gemcitabine in non-small cell lung cancer.

  2003cited by this paper
• Score tests for association between traits and haplotypes when linkage phase is ambiguous.

  2002cited by this paper
• Genetic determinants of lung cancer short-term survival: the role of glutathione-related genes.

  2002cited by this paper
• A direct approach to false discovery rates

  2002cited by this paper
• Expression of γ‐glutamyl cysteine synthetase in nonsmall cell lung carcinoma

  2001cited by this paper
• Expression of gamma-glutamyl cysteine synthetase in nonsmall cell lung carcinoma.

  2001cited by this paper
• Survival after treatment of small-cell lung cancer: an endless uphill battle.

  1997cited by this paper

• Comorbidity of hypertension and lung cancer: interplay of genetics and environment

  2025cites this paper
• Dual insights into gastric cancer: expression analysis and prognostic relevance of glutathione peroxidases

  2025cites this paper
• Mechanistic insights into cisplatin-induced ototoxicity: the central role of transient receptor potential channels

  2025cites this paper
• Associations between genetic variants in sphingolipid metabolism pathway genes and hepatitis B virus-related hepatocellular carcinoma survival

  2024cites this paper
• Gut Microbiome Was Highly Related to the Regulation of Metabolism in Lung Adenocarcinoma Patients

  2022cites this paper
• Associations Between Genetic Polymorphisms Within Transporter Genes and Clinical Response to Methotrexate in Chinese Rheumatoid Arthritis Patients: A Pilot Study

  2022cites this paper
• Associations Between Genetic Polymorphisms Within Transporter Genes and Clinical Response to Methotrexate in Chinese Rheumatoid Arthritis Patients: A Pilot Study

  2022cites this paper
• Sites of Synchronous Distant Metastases, Prognosis, and Nomogram for Small Cell Lung Cancer Patients with Bone Metastasis: A Large Cohort Retrospective Study

  2021cites this paper
• Current Understanding of Membrane Transporters as Regulators or Targets for Cisplatin-Induced Hearing Loss

  2021cites this paper
• Profiling of DNA damage and repair pathways in small cell lung cancer reveals a suppressive role in the immune landscape

  2021cites this paper
• Quantitative trait mapping in Diversity Outbred mice identifies novel genomic regions associated with the hepatic glutathione redox system

  2021cites this paper
• Association of PTEN Gene SNPs rs2299939 With PFS in Patients With Small Cell Lung Cancer Treated With Early Radiotherapy

  2020cites this paper
• Screening prognosis-related genes in glioblastoma by microarray analysis

  2020cites this paper
• Targeting Glutathione Metabolism: Partner in Crime in Anticancer Therapy

  2019cites this paper
• CircABCC2 Regulates Hepatocellular Cancer Progression by Decoying MiR-665

  2019cites this paper
• Genomic based analyses reveal unique mutational profiling and identify prognostic biomarker for overall survival in Chinese small-cell lung cancer.

  2019cites this paper
• Investigation on Gastric Cancer Susceptibility Genes in Chinese Early-onset Diffuse Gastric Cancer

  2019cites this paper
• Identifying reproducible cancer-associated highly expressed genes with important functional significances using multiple datasets

  2016cites this paper
• Prognostic impact of a 3‐MicroRNA signature in cytological samples of small cell lung cancer

  2016cites this paper
• Facteurs pronostiques et cancers bronchopulmonaires

  2015cites this paper
• DNA Repair Gene Polymorphisms in Relation to Non-Small Cell Lung Cancer Survival

  2015cites this paper
• Genetic Variations in Glutathione Pathway Genes Predict Cancer Recurrence in Patients Treated with Transurethral Resection and Bacillus Calmette–Guerin Instillation for Non-muscle Invasive Bladder Cancer

  2015cites this paper
• Evaluation of copy number variation and gene expression in neurofibromatosis type-1-associated malignant peripheral nerve sheath tumours

  2015cites this paper
• Associations of LIG4 and HSPB1 Genetic Polymorphisms with Risk of Radiation-Induced Lung Injury in Lung Cancer Patients Treated with Radiotherapy

  2015cites this paper
• Review of Cisplatin and Oxaliplatin in Current Immunogenic and Monoclonal Antibodies Perspective

  2014cites this paper
• Impact of genetic variability and treatment-related factors on outcome in early breast cancer patients receiving (neo-) adjuvant chemotherapy with 5-fluorouracil, epirubicin and cyclophosphamide, and docetaxel

  2014cites this paper
• Importance of ABCC1 for cancer therapy and prognosis

  2014cites this paper
• Review of Cisplatin and Oxaliplatin in Current Immunogenic and Monoclonal Antibody Treatments

  2014cites this paper
• Genetic variability in the multidrug resistance associated protein-1 (ABCC1/MRP1) predicts hematological toxicity in breast cancer patients receiving (neo-)adjuvant chemotherapy with 5-fluorouracil, epirubicin and cyclophosphamide (FEC).

  2013cites this paper
• Nuclear glutathione.

  2013cites this paper
• Biomarkers to tailor chemoradiation therapies.

  2012cites this paper
• A comprehensive study of polymorphisms in ABCB1, ABCC2 and ABCG2 and lung cancer chemotherapy response and prognosis

  2012cites this paper
• Genetic variations and patient-reported quality of life among patients with lung cancer.

  2012cites this paper
• Predictive value of multidrug resistance proteins, topoisomerases II and ERCC1 in small cell lung cancer: a systematic review.

  2011cites this paper
• Identification of SNPs associated with susceptibility for development of adverse reactions to radiotherapy.

  2011cites this paper
• Systematic Evaluation of Genetic Variants in Three Biological Pathways on Patient Survival in Low-Stage Non-small Cell Lung Cancer

  2011cites this paper
• Genetic Variations in Multiple Drug Action Pathways and Survival in Advanced Stage Non–Small Cell Lung Cancer Treated with Chemotherapy

  2011cites this paper
• 小细胞肺癌的诊疗进展

  2011cites this paper
• Vault RNA1 regulation of apoptosis in multidrug-resistant GLC4 small cell lung cancer cells

  2011cites this paper